Law360 recently interviewed Kevin O'Connor for their article, "Justices Clamp Down On Broad Patents In Amgen Decision." The U.S. Supreme Court's recent unanimous decision in Amgen Inc. v. Sanofi et al. has tightened the rules around broad patents, particularly in the biotechnology field. The court ruled that patent applications must be more tailored, enabling a skilled person to make and use the entire scope of the claimed invention.
Read the full article here (subscription may be required).